Compound heterozygosity as a cause of diagnostic difficulties in patients with hereditary diseases

Read full text Summarise with VIRAT
Authors: Лобанов Михаил Евгеньевич, Gumenyuk O.I., Yu. V. Chernenkov, O. S. Groznova, Z. G. Afaunova, P. D. Polyakova, M. A. Sukhanova, R. A. Kapyov, D. N. Shemirzov, L. M. Shipilova
Cited by: 0
References: 25

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background . Up to 40 % of patients with suspected monogenic disorders remain undiagnosed when using targeted gene panels or exome sequencing, particularly in cases of compound heterozygosity where one pathogenic variant goes undetected. The aim . To investigate the molecular and clinical features of compound heterozygous conditions in children with suspected inherited diseases and to evaluate the diagnostic utility of whole genome sequencing (WGS). Materials and methods . A prospective observational study was conducted between 2023 and 2025. The study included 7 pediatric patients (under 18 years old) with suspected genetic disorders in whom previous genetic testing identified only a single pathogenic variant. All patients underwent WGS followed by bioinformatic analysis and variant interpretation according to ACMG-AMP (2015) guidelines. No medical interventions were performed. The primary endpoint was the identification and phenotypic correlation of compound heterozygous mutations. Results . Compound heterozygous mutations were identified in all patients, totaling 14 variants across 7 genes (PAH, GALT, DNAH5, CHRNA3, SLC26A2, LAMA2, IDUA). Fifty percent of the variants had not been previously reported. Five patients had variants of uncertain significance (VUS) that followed by syndromic clinical presentations. WGS enabled confirmation of the diagnosis, refinement of the genotypic profile, adjustment of clinical management strategies, and improved diagnostic precision. No adverse events related to diagnostic procedures were observed. Conclusion . Whole genome sequencing demonstrated high diagnostic value in identifying compound heterozygous mutations, especially in cases where standard methods failed to detect the second variant. The detection of previously unreported mutations and clinically correlated VUS highlights the necessity of integrating WGS into routine pediatric genetic diagnostics.

Fields of Study & Subjects

Genomics and Rare Diseases Metabolism and Genetic Disorders Connective tissue disorders research

Publication details

Journal / source
Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук
Volume
11
Issue
1
Pages
63–72
Publication date
26 March 2026
Language
EN